Magma recharge and mush rejuvenation drive paroxysmal activity at Stromboli volcano.

Open-conduit basaltic volcanoes can be characterised by sudden large explosive events (paroxysms) that interrupt normal effusive and mild explosive activity. In June-August 2019, one major explosion and two paroxysms occurred at Stromboli volcano (Italy) within only 64 days. Here, via a multifaceted approach using clinopyroxene, we show arrival of mafic recharges up to a few days before the onset of these events and their effects on the eruption pattern at Stromboli, as a prime example of a persistently active, open-conduit basaltic volcano. Our data indicate a rejuvenated Stromboli plumbing system where the extant crystal mush is efficiently permeated by recharge magmas with minimum remobilisation promoting a direct linkage between the deeper and the shallow reservoirs that sustains the currently observed larger variability of eruptive behaviour. Our approach provides vital insights into magma dynamics and their effects on monitoring signals demonstrating the power of petrological studies in interpreting patterns of surficial activity.

Neuroprotection against stroke and encephalopathy after cardiac surgery.

Cerebral ischemia in the perioperative period is a major risk factor for stroke, encephalopathy, and cognitive decline after cardiothoracic surgery. After coronary artery bypass grafting, both stroke and encephalopathy can result in poor patient outcomes and increased mortality. Neuroprotection aims to lessen the severity and occurrence of further injury mediated by stroke and encephalopathy and to aid the recovery of conditions already present. Several pharmacological and non-pharmacological methods of neuroprotection have been investigated in experimental studies and in animal models, and, although some have shown effectiveness in protection of the central nervous system, for most, clinical research is lacking or did not show the expected results. This review summarizes the value and need for neuroprotection in the context of cardiothoracic surgery and examines the use and effectiveness of several agents and methods with an emphasis on clinical trials and clinically relevant neuroprotectants.

Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis.

Alzheimer's disease (AD) is the most common neurodegenerative dementia, with the accumulation of extracellular amyloid-ß and formation of neurofibrillary tau tangles as leading explanations of pathology. With the difficulties of studying the brain directly, it is hoped that identifying the effect of AD on the metabolite composition of biofluids will provide insights into underlying mechanisms of pathology. The present review identified 705 distinct metabolite reports representing 448 structurally distinct metabolites in six human biofluids, with 147 metabolites increased and 214 metabolites decreased with AD, while 80 metabolites showed inconsistent shifts. Sphingolipid, antioxidant, and glutamate metabolism were found to be strongly associated with AD and were selected for detailed investigation of their role in pathogenesis. In plasma, two ceramides increased and eight sphingomyelins decreased with AD, with total ceramides shown to increase in both serum and cerebrospinal fluid. In general antioxidants were shown to be depleted, with oxidative stress markers elevated in a range of biofluids in patients suggesting AD produces a pro-oxidative environment. Shifts in glutamate and glutamine and elevation of 4-hydroxy-2-nonenal suggests peroxidation of the astrocyte lipid bilayer resulting in reduced glutamate clearance from the synaptic cleft, suggesting a excitotoxicity component to AD pathology; however, due to inconsistencies in literature reports, reliable interpretation is difficult. The present review has shown that metabolite shifts in biofluids can provide valuable insights into potential pathological mechanisms in the brain, with sphingolipid, antioxidant, and glutamate metabolism being implicated in AD pathology.

Determining volcanic eruption styles on Earth and Mars from crystallinity measurements.

Both Earth and Mars possess different styles of explosive basaltic volcanism. Distinguishing phreatomagmatic eruptions, driven by magma-water interaction, from 'magmatic' explosive eruptions (that is, strombolian and plinian eruptions) is important for determining the presence of near-surface water or ice at the time of volcanism. Here we show that eruption styles can be broadly identified by relative variations in groundmass or bulk crystallinity determined by X-ray diffraction. Terrestrial analogue results indicate that rapidly quenched phreatomagmatic ejecta display lower groundmass crystallinity (<35%) than slower cooling ejecta from strombolian or plinian eruptions (>40%). Numerical modelling suggests Martian plinian eruptive plumes moderate cooling, allowing 20-30% syn-eruptive crystallization, and thus reduce the distinction between eruption styles on Mars. Analysis of Mars Curiosity rover CheMin X-ray diffraction results from Gale crater indicate that the crystallinity of Martian sediment (52-54%) is similar to pyroclastic rocks from Gusev crater, Mars, and consistent with widespread distribution of basaltic strombolian or plinian volcanic ejecta.